Comparison of the recommendation of international autoimmune hepatitis pathology group 2022 and the simplified criteria for autoimmune hepatitis 2008: A preliminary study.

Autoimmune hepatitis consensus recommendation for autoimmune hepatitis drug-induced-liver-injury interface hepatitis simplified criteria for autoimmune hepatitis

Journal

Hepatology forum
ISSN: 2757-7392
Titre abrégé: Hepatol Forum
Pays: Turkey
ID NLM: 9918351171306676

Informations de publication

Date de publication:
2024
Historique:
received: 31 10 2023
revised: 15 11 2023
accepted: 29 11 2023
medline: 15 7 2024
pubmed: 15 7 2024
entrez: 15 7 2024
Statut: epublish

Résumé

The histological diagnosis of autoimmune hepatitis (AIH) is challenging. A new consensus recommendation was provided by the International AIH Pathology Group to address the problems in the histological diagnosis. The purpose of this study is to compare the 2008 'simplified' criteria for AIH with the 'consensus recommendation' of 2022 in terms of diagnostic sensitivity. A retrospective analysis was conducted on pathological specimens of patients diagnosed with Autoimmune Hepatitis (AIH) between 2010 and 2022. Out of 188 patients enlisted, 88 were selected based on exclusion criteria. The specimens were examined by two experienced hepatopathologists and a resident pathologist. All specimens were analyzed using both the "simplified" criteria and the new consensus recommendations. Out of a total of 78 patients, the 2022 consensus recommendations raised the diagnostic category of 16 patients (20.5%) to a higher level. Six patients who were previously diagnosed as "atypical" were now considered "possible AIH", while 10 patients with a "compatible" diagnosis were elevated to "likely AIH" category. No patients were found to fall into a lower diagnostic category according to the new recommendations. A significant difference in diagnostic sensitivity was observed between the 2008 criteria and the 2022 consensus report (p<0.001). The 2022 consensus recommendation may be more sensitive in the diagnosis of AIH in comparison to the 2008 'simplified' histological criteria. More studies are needed both for the validation of the sensitivity of the new consensus recommendation and for the determination of the specificity.

Sections du résumé

Background and Aim UNASSIGNED
The histological diagnosis of autoimmune hepatitis (AIH) is challenging. A new consensus recommendation was provided by the International AIH Pathology Group to address the problems in the histological diagnosis. The purpose of this study is to compare the 2008 'simplified' criteria for AIH with the 'consensus recommendation' of 2022 in terms of diagnostic sensitivity.
Materials and Methods UNASSIGNED
A retrospective analysis was conducted on pathological specimens of patients diagnosed with Autoimmune Hepatitis (AIH) between 2010 and 2022. Out of 188 patients enlisted, 88 were selected based on exclusion criteria. The specimens were examined by two experienced hepatopathologists and a resident pathologist. All specimens were analyzed using both the "simplified" criteria and the new consensus recommendations.
Results UNASSIGNED
Out of a total of 78 patients, the 2022 consensus recommendations raised the diagnostic category of 16 patients (20.5%) to a higher level. Six patients who were previously diagnosed as "atypical" were now considered "possible AIH", while 10 patients with a "compatible" diagnosis were elevated to "likely AIH" category. No patients were found to fall into a lower diagnostic category according to the new recommendations. A significant difference in diagnostic sensitivity was observed between the 2008 criteria and the 2022 consensus report (p<0.001).
Conclusion UNASSIGNED
The 2022 consensus recommendation may be more sensitive in the diagnosis of AIH in comparison to the 2008 'simplified' histological criteria. More studies are needed both for the validation of the sensitivity of the new consensus recommendation and for the determination of the specificity.

Identifiants

pubmed: 39006139
doi: 10.14744/hf.2023.2023.0061
pii: hf-5-100
pmc: PMC11237242
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100-105

Déclaration de conflit d'intérêts

The authors have no conflict of interest to declare.

Auteurs

Kenan Moral (K)

Department of Gastroenterology and Hepatology, Gazi University School of Medicine, Ankara, Turkiye.

Berkay Simsek (B)

Department of Pathology, Gazi University School of Medicine, Ankara, Turkiye.

Veysel Baran Tomar (VB)

Department of Internal Medicine, Gazi University School of Medicine, Ankara, Turkiye.

Cihad Albayrak (C)

Department of Internal Medicine, Gazi University School of Medicine, Ankara, Turkiye.

Mustafa Ergin (M)

Department of Gastroenterology and Hepatology, Gazi University School of Medicine, Ankara, Turkiye.

Guner Kilic (G)

Department of Gastroenterology and Hepatology, Gazi University School of Medicine, Ankara, Turkiye.

Ali Karatas (A)

Department of Gastroenterology and Hepatology, Gazi University School of Medicine, Ankara, Turkiye.

Nergiz Ekmen (N)

Department of Gastroenterology and Hepatology, Gazi University School of Medicine, Ankara, Turkiye.

Murat Kekilli (M)

Department of Gastroenterology and Hepatology, Gazi University School of Medicine, Ankara, Turkiye.

Mehmet Ibis (M)

Department of Gastroenterology and Hepatology, Gazi University School of Medicine, Ankara, Turkiye.

Tarkan Karakan (T)

Department of Gastroenterology and Hepatology, Gazi University School of Medicine, Ankara, Turkiye.

Mehmet Cindoruk (M)

Department of Gastroenterology and Hepatology, Gazi University School of Medicine, Ankara, Turkiye.

Guldal Esendagli (G)

Department of Pathology, Gazi University School of Medicine, Ankara, Turkiye.

Gulen Akyol (G)

Department of Pathology, Gazi University School of Medicine, Ankara, Turkiye.

Classifications MeSH